The Relevance of Occult Axillary Micrometastasis in Ductal Carcinoma In Situ: A Clinicopathologic Study with Long-Term Follow-Up

Cancer

Volumn 98, Issue 10, 2003, Pages 2105-2113

  Lata, Jonathan F ^a   Young, Steven M ^a   Velilla, Rowena E ^a   Santoro, Elissa J ^a   Templeton, Sandra F ^a  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

Ductal carcinoma in situ; Immunohistochemistry; Lymph nodes; Microinvasion; Micrometastasis; Sentinel

Indexed keywords

KERATIN; PARAFFIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 0242575236     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11761     Document Type: Article

References (20)

1. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual, 6th edition. New York: Springer-Verlag, 2002.
2. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol. 2000;7:15-20.
3. Trojani M, de Mascarel I, Bonichon F, Coindre JM, Delsol G. Micrometastasis to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987;55:303-306.
4. Colpaert C, Vermeulen P, Jeuris W, et al. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by features of the primary tumor. J Pathol. 2001;193:442-449.
5. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma. Cancer. 2000;88:1099-1107.
6. Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG, McGuckin MA. Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol. 2002;26:1286-1295.
7. Huvos AG, Hutter R, Berg JW. Significance of axillary macmetastases and micrometastases in mammary cancer. Ann Surg. 1971;173:44-46.
8. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast cancer: reviewing the dilemma. Cancer. 1997;80:1188-1197.
9. Nasser IA, Lee AK, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastasis in "nodenegative" breast cancer. Hum Pathol. 1993;24:950-957.
10. Millis RR, Springall R, Lee AH, Ryder K, Rytina ER, Fentiman IS. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer. 2002;86: 396-401.
11. Keshtgar MR, Ell PJ. Clinical role of sentinel lymph node biopsy in breast cancer. Lancet Oncol. 2002;3:105-110.
12. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol. 2000;7:636-642.
13. Tan PH. Pathology of ductal carcinoma in situ of the breast: a heterogeneous entity in need of greater understanding. Ann Acad Med Singapore. 2001;30:671-676; quiz, 677.
14. Silverstein MJ, Parker R, Grotting JC, Cote RJ, Russell CA. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies. J Am Coll Surg. 2001;192: 196-214.
15. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node metastasis from breast cancers. Lancet. 1990;335:1565-1568.
16. Ishida M, Kitamura K, Kinoshita J, Sasaki M, Kuwahara H, Sugimachi K. Detection of micrometastasis in the sentinel lymph nodes in breast cancer. Surgery. 2002;131(1 Suppl): S211-S216.
17. Tamhane R, Dahlstrom JE, McCallum DD, Buckingham JM. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann Surg Oncol. 2002;9:999-1003.
18. Elson CE, Kufe D, Johnston WW. Immunohistochemical detection and significance of axillary lymph node micrometastasis in breast carcinoma. A study of 97 cases. Anal Quant Cytol Histol. 1993;15:171-178.
19. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 1999;354:896-900.
20. Cutuli B, Velten M, Martin C. Assessment of axillary lymph node involvement in small breast cancer: analysis of 893 cases. Clin Breast Cancer. 2001;2:59-65.